RAPT Therapeutics, Inc. (RAPT) Retained Earnings (2020 - 2024)
RAPT Therapeutics (RAPT) has disclosed Retained Earnings for 5 consecutive years, with $107000.0 as the latest value for Q3 2024.
- Quarterly Retained Earnings rose 100.02% to $107000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $107000.0 through Sep 2024, up 100.02% year-over-year, with the annual reading at -$484.7 million for FY2023, 31.75% down from the prior year.
- Retained Earnings hit $107000.0 in Q3 2024 for RAPT Therapeutics, up from -$542.9 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $177000.0 in Q2 2020 to a low of -$542.9 million in Q2 2024.
- Historically, Retained Earnings has averaged -$207.5 million across 5 years, with a median of -$214.8 million in 2020.
- Biggest five-year swings in Retained Earnings: crashed 161018.52% in 2022 and later skyrocketed 100.02% in 2024.
- Year by year, Retained Earnings stood at -$214.8 million in 2020, then plummeted by 32.21% to -$284.0 million in 2021, then dropped by 29.52% to -$367.9 million in 2022, then tumbled by 31.75% to -$484.7 million in 2023, then skyrocketed by 100.02% to $107000.0 in 2024.
- Business Quant data shows Retained Earnings for RAPT at $107000.0 in Q3 2024, -$542.9 million in Q2 2024, and -$10000.0 in Q1 2024.